$32.47
-1.00-2.99%
Last update: Nov 11, 11:18 AM
Oscar Health Inc
OSCRNYSE
Oscar Health rose 125.4% from $14.85 to $33.47, ahead of the S&P 500's +9.8%. Its worst day was Aug 6 (−11.9%), and its low came Mar 30 at $10.85.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Oscar Health shares rose 22.3%, while the S&P 500 rose 1.5%.
+22.3%, the year's best day, on 59M shares, the year's heaviest volume · S&P 500 +1.5%
EPS of $-1.24 missed the $-0.89 estimate on $2.8B revenue (est. $3.2B); FY revenue guidance of $18.7B–$19.0B against the $13.5B consensus.
Story events cover the past 12 months · Times ET
+1.7% · S&P 500 −0.3%
Oscar Health closed at its lowest level of the year, 26.9% below where the year started.
−2.6% · S&P 500 −0.3%
Oscar Health Inc shares are up Wednesday after an SEC filing showed CEO Mark Bertolini bought 1 million Class A shares in a private placement.
+12.9% · S&P 500 +2.5%
EPS of $2.07 beat the $1.12 estimate on $4.6B revenue (est. $4.9B); FY revenue guidance of $18.7B–$19.0B against the $18.8B consensus.
+10.6% · S&P 500 +1.4%
Oscar Health shares rose 15.1%, while the S&P 500 rose 0.4%.
+15.1% · S&P 500 +0.4%
Oscar Health shares rose 11.9%, while the S&P 500 fell 0.1%.
+11.9% · S&P 500 −0.1%
Oscar Health shares rose 10.8%, while the S&P 500 rose 0.2%.
+10.8% · S&P 500 +0.2%
EPS of $1.10 beat the $0.32 estimate on $4.9B revenue (est. $4.8B); FY revenue guidance of $18.7B–$19.0B against the $18.6B consensus.
−11.9%, the year's worst day · S&P 500 −0.2%
EPS of $0.49 beat the $-0.16 estimate on $5.1B revenue (est. $4.7B); FY revenue guidance of $19.0B–$19.3B against the $18.7B consensus.
−5.7% · S&P 500 −4.4%
Where it ended: a close of $33.47 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 9, 2027 (EPS est. $-1.13, revenue est. $4.5B).
Nothing in the past 12 months.
All OSCR dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OSCR and SPY from Benzinga historical bars. Not investment advice.
